Exelixis
EXEL
#2105
Rank
$5.23 B
Marketcap
$16.28
Share price
-1.75%
Change (1 day)
-20.00%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: $5.23 Billion

As of September 2022 Exelixis has a market cap of $5.23 Billion. This makes Exelixis the world's 2105th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$5.23 B-9.41%
2021$5.78 B-7.11%
2020$6.22 B16.3%
2019$5.35 B-9.24%
2018$5.89 B-34.42%
2017$8.99 B108.06%
2016$4.32 B236.22%
2015$1.28 B355.78%
2014$0.28 B-75.06%
2013$1.13 B34.75%
2012$0.83 B30.78%
2011$0.64 B-28.46%
2010$0.89 B12.81%
2009$0.79 B50.04%
2008$0.53 B-41.36%
2007$0.90 B4.63%
2006$0.86 B9.96%
2005$0.78 B10.28%
2004$0.71 B41.74%
2003$0.50 B5.8%
2002$0.47 B-49.09%
2001$0.93 B

End of Day market cap according to different sources

On Sep 24th, 2022 the market cap of Exelixis was reported to be:

$5.15 Billion
by Yahoo Finance
$5.23 Billion
by CompaniesMarketCap
$5.23 Billion
by Nasdaq
$5.23 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$438.33 B 8,266.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$247.39 B 4,621.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$127.84 B 2,340.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$96.51 B 1,742.18%๐Ÿ‡ซ๐Ÿ‡ท France
$219.83 B 4,095.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$150.98 B 2,781.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$73.86 B 1,309.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
$67.59 M-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.26 B-94.88%๐Ÿ‡บ๐Ÿ‡ธ USA